Understanding SR9009 Driada Medical
SR-9009 Stenabolic is a Rev-Erbα nuclear receptor agonist that regulates circadian rhythm gene expression and metabolic pathways in preclinical models. This metabolic modulator from Driada Medical operates through agonism of Rev-Erbα nuclear receptors, influencing mitochondrial biogenesis and lipid metabolism in laboratory research. Unlike SARMs compounds, SR-9009 functions through circadian biology mechanisms rather than androgen receptor pathways. Research applications at Stroid UK Shop focus on metabolic syndrome studies and energy expenditure investigations in controlled laboratory environments.
Laboratory Research Applications
Investigators examine SR-9009’s effects on circadian rhythm regulation and metabolic dysfunction models in preclinical studies. Research demonstrates modulation of fatty acid oxidation pathways and cellular energy expenditure through Rev-Erbα activation. Laboratory protocols evaluate mitochondrial biogenesis enhancement and lipid metabolism alterations in cell culture systems. Studies within the broader Stenabolic research category investigate circadian clock gene expression changes and metabolic pathway alterations. Comparative research with traditional SARMs compounds highlights distinct mechanisms of action through nuclear receptor pathways. Advanced metabolic research often combines SR-9009 investigations with peptide studies examining complementary energy regulation pathways.
Research Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | SR-9009 (Stenabolic) |
| CAS Number | 1379686-30-2 |
| Molecular Formula | C₂₀H₂₄ClN₃O₄S |
| Molecular Weight | 437.94 g/mol |
| Mechanism | Rev-Erbα nuclear receptor agonist |
| Storage | Room temperature, dry environment |
Research Compliance
This SR-9009 Stenabolic product is intended strictly for in-vitro laboratory research applications only. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must ensure compliance with institutional guidelines and applicable regulations when conducting studies with this metabolic modulator compound.
